North Crest Asset Manangement, LLC Mersana Therapeutics, Inc. Transaction History
North Crest Asset Manangement, LLC
- $3.19 Billion
- Q1 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 16,069 shares of MRSN stock, worth $5,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,069Holding current value
$5,784% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRSN
# of Institutions
140Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Nextech Invest Ag12.1MShares$4.34 Million3.22% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$4.08 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$3.69 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$3.12 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$3.02 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $35M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...